Milestone Pharmaceuticals (MIST) Non-Current Assets (2018 - 2026)

Milestone Pharmaceuticals' Non-Current Assets history runs 9 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• Quarterly Non-Current Assets rose 5.04% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (down 17.07% YoY) and the FY2025 annual result came in at $1.6 million, up 4.26% from the prior year.
• Non-Current Assets was $1.5 million for Q1 2026 at Milestone Pharmaceuticals, down from $1.6 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $2.8 million in Q3 2022 and bottomed at $797000.0 in Q2 2022.
• A 5-year average of $1.8 million and a median of $1.7 million in 2024 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2023 — Non-Current Assets soared 208.76% — and 2025, when it slumped 37.06%.
• Milestone Pharmaceuticals' Non-Current Assets stood at $2.7 million in 2022, then slipped by 18.13% to $2.2 million in 2023, then fell by 28.3% to $1.6 million in 2024, then increased by 4.26% to $1.6 million in 2025, then decreased by 9.7% to $1.5 million in 2026.
• Business Quant data shows MIST's Non-Current Assets at $1.5 million in Q1 2026, $1.6 million in Q4 2025, and $1.1 million in Q3 2025.